Oxygenta Pharmaceutical Share Price
Know More₹58.500.00 (0.00%)
6-Feb-2026BSE : 524636
Sector : Health care
ISIN Code : INE102E01018
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 06-Feb-2026
| Market Cap (₹ Cr) | 216 |
Traded Value (₹ Cr) | 0.01 |
Volume (Shares) | 1,011 |
Face Value (₹) | 10 |
52-Week High (₹) | 133.50 |
52-Week High Date | 09-Jun-2025 |
52-Week Low (₹) | 51.31 |
52-Week Low Date | 21-Jan-2026 |
All Time High (₹) | 133.50 |
All Time High Date | 09-Jun-2025 |
All Time Low (₹) | 2.95 |
All Time Low Date | 22-Jul-2008 |
Oxygenta Pharmaceutical Ltd
Market News
Oxygenta Pharma Announcement
Oxygenta Pharmaceutical Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 216 |
| EPS - TTM (₹) [S] | -4.88 |
| P/E Ratio (X) [S] | -11.99 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | - |
| Book Value Share (₹) [S] | -9.92 |
| P/B Ratio (₹) [S] | -5.90 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Data Not Found | |||
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 57.50 58.51 |
| Week Low/High (₹) | 56.03 64.00 |
| Month Low/High (₹) | 51.31 64.00 |
| Year Low/High (₹) | 51.31 134.00 |
| All time Low/High (₹) | 2.95 134.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -6.71% | - | 1.59% | 1.47% |
| 1 Month | 5.48% | - | -1.74% | -1.85% |
| 3 Month | -11.64% | - | 0.15% | 0.38% |
| 6 Month | -40.58% | - | 3.77% | 4.56% |
| 1 Year | -32.53% | - | 7.07% | 8.86% |
| 3 Year | 111.96% | - | 38.13% | 44.63% |
Company Info
Company Information
WTD & Executive Director : Chandra Mouliswar Reddy Gangavaram
WTD & Executive Director : Balasubba Reddy Mamilla
Non Executive Director : Vedavathi Gangavaram
Independent Non Exe. Director : Veera Reddy Arava
Independent Non Exe. Director : Sidda Reddy Kanuparthi
Independent Non Exe. Director : Sharvari Swapnil Shinde
Company Sec. & Compli. Officer : Ms. Kumkum Bajaj
Registered Office: Survey No 252/1 Aroor Village, Sadasivapet Mandal,Medak,Telangana-502291 Ph: 91-08455-250080/250280
FAQs about Oxygenta Pharmaceutical Ltd
1. What's the Oxygenta Pharmaceutical Ltd share price today?
Oxygenta Pharmaceutical Ltd share price was Rs 58.50 at close on 6th Feb 2026. Oxygenta Pharmaceutical Ltd share price was up by 0.00% over the previous closing price of Rs 58.50. Oxygenta Pharmaceutical Ltd share price trend:
- Last 1 Month: Oxygenta Pharmaceutical Ltd share price moved up by 5.48% on BSE.
- Last 3 Months: Oxygenta Pharmaceutical Ltd share price moved down by 11.64% on BSE.
- Last 12 Months: Oxygenta Pharmaceutical Ltd share price moved down by 32.53% on BSE.
- Last 3 Years: Oxygenta Pharmaceutical Ltd share price moved up by 111.96% on BSE.
2. How can I quickly analyse the performance of the Oxygenta Pharmaceutical Ltd stock?
The performance of the Oxygenta Pharmaceutical Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is -11.99
- Price to book value ratio is -5.90
- The EPS (trailing 12 months) of the Oxygenta Pharmaceutical Ltd stock is Rs -4.88
3. What is the market cap of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a market capitalisation of Rs 216 crore.
4. What is Oxygenta Pharmaceutical Ltd's 52-week high/low share price?
The Oxygenta Pharmaceutical Ltd’s 52-week high share price is Rs 133.50 and 52-week low share price is Rs 51.31.
6. Which are Oxygenta Pharmaceutical Ltd’s peers in the Health care sector?
Oxygenta Pharmaceutical Ltd’s top 5 peers in the Health care sector are Sanjiv.Parant., Syschem (India), BDH Industries, Oxygenta Pharma, Ambalal Sarabhai, Aarey Drugs, Brooks Lab..
7. Who owns how much in Oxygenta Pharmaceutical Ltd?
Key changes to the Oxygenta Pharmaceutical Ltd shareholding are as follows:
- Promoter holding in Oxygenta Pharmaceutical Ltd has gone up to 55.93 per cent as of Dec 2025 from 51.12 per cent as of Mar 2025.